Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity

Area of Science:

• Neuroscience
• Rehabilitation Medicine
• Clinical Electrophysiology

Background:

• Post-stroke spasticity (PSS) involves motor and sensory processing deficits.
• Botulinum toxin A (BoNT-A) is used to treat PSS, but its central effects on the sensorimotor cortex are debated.
• Electrophysiological evidence of cortical changes following BoNT-A treatment remains controversial.

Purpose of the Study:

• To investigate central nervous system changes in the sensorimotor cortex of post-stroke spasticity patients treated with BoNT-A.
• To evaluate the utility of somatosensory evoked potentials (SEPs) in assessing BoNT-A-induced cortical modulations.
• To correlate electrophysiological findings with clinical improvements in PSS.

Main Methods:

• Observational study of 31 chronic stroke patients with upper limb PSS.
• Treatment involved BoNT-A injections and physiotherapy.
• Median nerve SEPs were recorded before (W0) and after (W4, W11) treatment, analyzing precentral (P22/N30) and postcentral (N20/P23) components.
• Clinical assessment using the Modified Ashworth Scale (MAS).

Main Results:

• Baseline (W0) postcentral SEPs were significantly reduced over the affected cortex.
• Despite significant clinical improvement in PSS at follow-up (W4, W11), cortical SEPs showed no significant changes attributable to BoNT-A and/or physiotherapy.
• This suggests a dissociation between clinical recovery and measurable SEP alterations.

Conclusions:

• Conventional SEPs appear to have limited value in detecting central sensorimotor cortex changes after BoNT-A treatment in PSS.
• Further research is needed to explore alternative electrophysiological methods to elucidate the central mechanisms of BoNT-A therapy.
• The study highlights the complexity of sensorimotor cortex adaptation in response to PSS treatment.